Details for Patent: 9,827,241
✉ Email this page to a colleague
▶ Start for $1
Remove trial restrictions
Which drugs does patent 9,827,241 protect, and when does it expire?
Patent 9,827,241 protects SUBLOCADE and is included in one NDA.
This patent has forty patent family members in twenty-nine countries.
Summary for Patent: 9,827,241
Title: | Injectable flowable composition comprising buprenorphine |
Abstract: | The present invention is directed to a buprenorphine sustained release delivery system capable of delivering buprenorphine, a metabolite, or a prodrug thereof for a duration of about 14 days to about 3 months. The buprenorphine sustained release delivery system includes a flowable composition and a solid implant for the sustained release of buprenorphine, a metabolite, or a prodrug thereof. The implant is produced from the flowable composition. The buprenorphine sustained release delivery system provides in situ 1-month and 3-month release profiles characterized by an exceptionally high bioavailability and minimal risk of permanent tissue damage and typically no risk of muscle necrosis. |
Inventor(s): | Norton; Richard L. (Fort Collins, CO), Watkins; Andrew (Fort Collins, CO), Zhou; Mingxing (Fort Collins, CO) |
Assignee: | Indivior UK Limited (Berkshire, GB) |
Application Number: | 15/623,191 |
Patent Claim Types: see list of patent claims | Use; Composition; Compound; Device; |
Drugs Protected by US Patent 9,827,241
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Indivior Inc | SUBLOCADE | buprenorphine | SOLUTION, EXTENDED RELEASE;SUBCUTANEOUS | 209819-001 | Nov 30, 2017 | RX | Yes | No | See Plans and Pricing | See Plans and Pricing | Y | TREATING OPIOID DEPENDENCY BY ADMINISTERING BUPRENORPHINE | See Plans and Pricing | |||
Indivior Inc | SUBLOCADE | buprenorphine | SOLUTION, EXTENDED RELEASE;SUBCUTANEOUS | 209819-001 | Nov 30, 2017 | RX | Yes | No | See Plans and Pricing | See Plans and Pricing | Y | TREATING OPIOID ADDICTION BY ADMINISTRATION OF BUPRENORPHINE | See Plans and Pricing | |||
Indivior Inc | SUBLOCADE | buprenorphine | SOLUTION, EXTENDED RELEASE;SUBCUTANEOUS | 209819-001 | Nov 30, 2017 | RX | Yes | No | See Plans and Pricing | See Plans and Pricing | Y | TREATING OPIOID DEPENDENCY BY SUBCUTANEOUSLY ADMINISTERING BUPRENORPHINE | See Plans and Pricing | |||
Indivior Inc | SUBLOCADE | buprenorphine | SOLUTION, EXTENDED RELEASE;SUBCUTANEOUS | 209819-001 | Nov 30, 2017 | RX | Yes | No | See Plans and Pricing | See Plans and Pricing | Y | TREATING OPIOID ADDICTION BY 100 MG OR 300 MG DOSE BUPRENORPHINE | See Plans and Pricing | |||
Indivior Inc | SUBLOCADE | buprenorphine | SOLUTION, EXTENDED RELEASE;SUBCUTANEOUS | 209819-001 | Nov 30, 2017 | RX | Yes | No | See Plans and Pricing | See Plans and Pricing | Y | TREATING OPIOID DEPENDENCY BY ADMINISTERING BUPRENORPHINE ONCE PER MONTH | See Plans and Pricing | |||
Indivior Inc | SUBLOCADE | buprenorphine | SOLUTION, EXTENDED RELEASE;SUBCUTANEOUS | 209819-002 | Nov 30, 2017 | RX | Yes | Yes | See Plans and Pricing | See Plans and Pricing | Y | TREATING OPIOID DEPENDENCY BY SUBCUTANEOUSLY ADMINISTERING BUPRENORPHINE | See Plans and Pricing | |||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
Foreign Priority and PCT Information for Patent: 9,827,241
Foriegn Application Priority Data | ||
Foreign Country | Foreign Patent Number | Foreign Patent Date |
United Kingdom | 10099549.5 | Jun 8, 2010 |
United Kingdom | PCT/GB2011/051057 | Jun 6, 2011 |
International Family Members for US Patent 9,827,241
Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
---|---|---|---|---|---|
Australia | 2011263478 | See Plans and Pricing | |||
Brazil | 112012031290 | See Plans and Pricing | |||
Canada | 2801676 | See Plans and Pricing | |||
Chile | 2012003462 | See Plans and Pricing | |||
China | 103079544 | See Plans and Pricing | |||
Colombia | 6670529 | See Plans and Pricing | |||
>Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |